Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1975-03-21
1977-05-24
Coughlan, Jr., Paul M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
260287AR, 424258, 260268BQ, A61K 3147, C07D21544
Patent
active
040256294
ABSTRACT:
Novel p-(trifluoromethylquinolylamino)benzamides are provided, for example, p-[(7-trifluoromethyl-4-quinolyl)-amino]-N,N-(3-methyl-3-azapentamethylene )benzamide and 1-[p-[[7-(trifluoromethyl)-4-quinolyl]amino]benzoyl]piperazine dihydrochloride. Also provided are pharmaceutical dosage unit forms for systemic administration and methods for their systemic administration. The compound, dosage unit forms and methods of systemic administration are useful in obtaining antihypertensive and anti-anxiety effects in mammals.
REFERENCES:
patent: 2940974 (1960-06-01), Surrey
patent: 3632761 (1972-01-01), Graham et al.
Fukami, Amides of 4-Quinolylamino Acid as Chemotherapeutic Agents, Thesis, (1967), p. 8.
Coughlan, Jr. Paul M.
Killinger John J.
Saliwanchik Roman
The Upjohn Company
LandOfFree
P-(trifluoromethylquinolylamino)benzamides, pharmaceutical dosag does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with P-(trifluoromethylquinolylamino)benzamides, pharmaceutical dosag, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and P-(trifluoromethylquinolylamino)benzamides, pharmaceutical dosag will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-537647